JHS Svendgaard Laboratories (NSE:JHS) Marketable Securities: ₹168 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JHS JHS Svendgaard Laboratories Ltd NSE:JHS
45 GF Score
Price ₹7.67
GF Value ₹22.89
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is JHS Svendgaard Laboratories Marketable Securities?

JHS Svendgaard Laboratories NSE:JHS +0.39% 45 Marketable Securities is ₹168 Mil as of Mar. 2026. GuruFocus rates NSE:JHS with a GF Score™ of 45/100 and a GF Value™ of ₹22.89 (Possible Value Trap). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. JHS Svendgaard Laboratories's Marketable Securities for the quarter that ended in Mar. 2026 was ₹168 Mil.

JHS Svendgaard Laboratories's annual Marketable Securities increased from Mar. 2024 (₹4 Mil) to Mar. 2025 (₹118 Mil) and increased from Mar. 2025 (₹118 Mil) to Mar. 2026 (₹168 Mil).

JHS Svendgaard Laboratories  (NSE:JHS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

JHS Svendgaard Laboratories Marketable Securities Related Terms

JHS Svendgaard Laboratories Marketable Securities Historical Data

* Premium members only.

The historical data trend for JHS Svendgaard Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JHS Svendgaard Laboratories Marketable Securities Chart

JHS Svendgaard Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.31 4.94 3.51 117.70 167.54

JHS Svendgaard Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.70 0.00 31.92 0.00 167.54
NSE:JHS
45GF Score
JHS Svendgaard Laboratories Ltd NSE:JHS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JHS Svendgaard Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹168 Mil mean?
JHS Svendgaard Laboratories (NSE:JHS) has a Marketable Securities of ₹168 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on JHS Svendgaard Laboratories and its competitors.
Is JHS Svendgaard Laboratories' Marketable Securities too high?
JHS Svendgaard Laboratories' current Marketable Securities is ₹168 Mil. Overall, JHS Svendgaard Laboratories has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JHS Svendgaard Laboratories' Marketable Securities compare to PG and CL?
JHS Svendgaard Laboratories' Marketable Securities of ₹168 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Consumer Packaged Goods company?
A good Marketable Securities depends on the Consumer Packaged Goods industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on JHS Svendgaard Laboratories and its competitors. JHS Svendgaard Laboratories's current Marketable Securities is ₹168 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JHS Svendgaard Laboratories stock overvalued right now?
Based on GuruFocus' analysis, JHS Svendgaard Laboratories (NSE:JHS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹22.89, compared to a current price of ₹7.67 — trading 66.5% below its estimated fair value. The current Marketable Securities is ₹168 Mil. JHS Svendgaard Laboratories' overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For JHS Svendgaard Laboratories (NSE:JHS), the current Marketable Securities is ₹168 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JHS Svendgaard Laboratories (NSE:JHS) Overvalued in 2026?

Based on GuruFocus' analysis, JHS Svendgaard Laboratories stock appears to be undervalued. The current stock price of ₹7.67 is trading 66.5% below its estimated GF Value™ of ₹22.89. GuruFocus considers JHS Svendgaard Laboratories to be Possible Value Trap.

Key valuation signals for NSE:JHS:

  • Marketable Securities: ₹168 Mil
  • GF Value™: ₹22.89 vs. price of ₹7.67 (66.5% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the NSE:JHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JHS Svendgaard Laboratories Business Description

Other Exchanges 532771:India
Address Mathura Road, B-1/E-23, Mohan Co-operative Industrial Area, New Delhi, IND, 110044
JHS Svendgaard Laboratories Ltd is engaged in manufacturing a range of oral and dental products for elite national and international brands. The main portfolio of the Group is to carry out manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanizers, and job work of detergent powder. The Company is into manufacturing toothpaste, toothbrushes, Talcum, and Others. The toothbrushes segment generates the key revenue.
45GF Score

Get the complete analysis for NSE:JHS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.67
Price
₹22.89
GF Value